U.S. Patient Survey on Direct-to-Consumer Drug Advertising Impact, 2001-2002

A patient survey dataset from a study by Joel S. Weissman of Harvard University, conducted between July 2001 and January 2002. It addresses the public health impact of Direct-to-Consumer advertising for prescription drugs in the United States. Survey questions cover health status, experiences with drug ads, physician visit outcomes, and insurance coverage.

Use Cases

• Analyzing correlations between patient exposure to drug advertisements and physician visit outcomes based on survey questions.
• Modeling patient satisfaction and side effects from prescribed drugs based on self-reported outcomes.
• Investigating demographic factors influencing patient discussions with doctors about advertised drugs based on background variables.

Strengths

• Includes detailed patient self-reports on five main topics: health status, ad exposure, doctor visits, outcomes, and insurance.
• Contains background variables such as sex, age, race, marital status, employment, education, and income level.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Harvard University (Joel S. Weissman)

Collection Method

Patient survey

Time Range

July 2001 - January 2002

Geography

United States